Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001689548-26-000039
Filing Date
2026-04-30
Accepted
2026-04-30 16:16:24
Documents
25
Period of Report
2026-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A prax-20260430.htm   iXBRL DEF 14A 649017
5 prax-20260430_g1.jpg GRAPHIC 7104
6 prax-20260430_g10.jpg GRAPHIC 867658
7 prax-20260430_g11.jpg GRAPHIC 198724
8 prax-20260430_g2.jpg GRAPHIC 40613
9 prax-20260430_g3.jpg GRAPHIC 14065
10 prax-20260430_g4.jpg GRAPHIC 1762
11 prax-20260430_g5.jpg GRAPHIC 309212
12 prax-20260430_g6.jpg GRAPHIC 212096
13 prax-20260430_g7.jpg GRAPHIC 74577
14 prax-20260430_g8.jpg GRAPHIC 79045
15 prax-20260430_g9.jpg GRAPHIC 61825
  Complete submission text file 0001689548-26-000039.txt   5568909

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20260430.xsd EX-101.SCH 3772
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20260430_lab.xml EX-101.LAB 7628
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20260430_pre.xml EX-101.PRE 4763
28 EXTRACTED XBRL INSTANCE DOCUMENT prax-20260430_htm.xml XML 91290
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39620 | Film No.: 26925630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)